NEW YORK (GenomeWeb News) – Cyntellect today said that it will collaborate with the University of Florida Interdisciplinary Center for Biotechnology Research on the purification and analysis of cancer stem cells.
The partners will use Cyntellect’s LEAP system to purify the stem cells “and their progeny without disturbing them from their growing environment,” said Cyntellect. The San Diego-based firm will receive certain payments and commercial rights to discoveries under the collaboration. Further details were not provided.
The collaboration will seek to “gain a better understanding of the molecular machinery, signaling pathways, and markers associated with rare cells, such as CSCs,” said Cyntellect CEO Fred Koller in a statement. “This information will be paramount to innovating novel drug development strategies and developing new cutting-edge diagnostics for crippling diseases, such as cancer.”
Cyntellect said that the alliance with the University of Florida is the second “major” LEAP collaboration this year. It expects further collaboration sin 2009 aimed at leveraging cell manipulation for discovering new drugs and cellular therapies and developing new cell-based diagnostics.